Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History

By sjmartinez • May 19, 2023

Izquierdo M, Marion CR, Genese F, Newell JD, O'Neal WK, Li X, Hawkins GA, Barjaktarevic I, Barr RG, Christenson S, Cooper CB, Couper D, Curtis J, Han MK, Hansel NN, Kanner RE, Martinez FJ, Paine R 3rd, Tejwani V, Woodruff PG, Zein JG, Hoffman EA, Peters SP, Meyers DA, Bleecker ER, Ortega VE; National Heart, Lung and Blood Institute’s SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) investigators. Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History. Chronic Obstr Pulm Dis. 2023 May 16. doi: 10.15326/jcopdf.2022.0388. Epub ahead of print. PMID: 37199731.

Tags: alpha-1 antitrypsin, bronchiectasis, COPD, lung function, Publications, Pulmonary, Critical Care & Sleep Medicine

Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain

Rodriguez A, Zeng C, Hays RD, Herman PM, Edelen MO. Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with[...]

Diabetic Cardiomyopathy: What Clinicians Should Know

Smati H, Qadeer YK, Rodriguez M, Moras E, Fonarow GC, Isaacs SD, Marwick TH, Krittanawong C. Diabetic Cardiomyopathy: What Clinicians Should Know. Am J Med.[...]

Heart Failure With Preserved Ejection Fraction-A Role for Invasive Hemodynamics

Fonarow GC, Udelson JE, Yancy CW. Heart Failure With Preserved Ejection Fraction-A Role for Invasive Hemodynamics. JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3764. Epub ahead[...]